We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
- Authors
Ratner, L; Lee, J; Tang, S; Redden, D; Hamzeh, F; Herndier, B; Scadden, D; Kaplan, L; Ambinder, R; Levine, A; Harrington, W; Grochow, L; Flexner, C; Tan, B; Straus, D; AIDS Malignancy Consortium
- Abstract
This study investigated the efficacy, toxicity, and pharmacokinetic interactions resulting from simultaneous combination chemotherapy and highly active antiretroviral therapy (HAART) for patients with human immunodeficiency virus (HIV)-associated non-Hodgkin's lymphoma (NHL). In addition, the effects on viral load, CD4 counts, and opportunistic infections were examined with the use of combination chemotherapy combined with HAART.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Vol 19, Issue 8, p2171
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2001.19.8.2171